4//SEC Filing
Horn Kinney 4
Accession 0001415889-21-005866
CIK 0001750284other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:25 PM ET
Size
9.1 KB
Accession
0001415889-21-005866
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-10$2.06/sh+5,251$10,838→ 7,709 total - Sale
Common Stock
2021-12-10$10.39/sh−5,251$54,558→ 2,458 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-10−5,251→ 157,540 totalExercise: $2.06Exp: 2030-06-09→ Common Stock (5,251 underlying)
Footnotes (4)
- [F1]Includes 668 shares acquired under the issuer's Employee Stock Purchase Plan on November 15, 2021.
- [F2]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F3]The weighted average sale price for the transaction reported was $10.39, and the range of prices were between $10.18 and $11.11. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831215
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:25 PM ET
- Size
- 9.1 KB